Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ACTs for Malaria in Cameroonian Children
NCT00297882Phase 3Completed
- Sponsor
- London School of Hygiene & Tropical Medicine
- Start
- Jul 2006
- Primary completion
- Apr 2009
- Modality
- Small Molecules
01
Overview
Phase 3, randomised, open-label trial of amodiaquine and artesunate in malaria (2 arms), sponsored by London School of Hygiene & Tropical Medicine. Primary endpoint: Cure Rate on Day 28. Started Jul 2006; status: completed.
02
Drugs
amodiaquineartesunate
03
Conditions
malaria
Beyond the preview
Go deeper on NCT00297882.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00297882.